A 42-year-old woman from Mumbai presents with a 6-month history of recurrent episodes of palpitations, chest tightness, and a sensation of impending doom. During an episode in the clinic, she is noted to have a heart rate of 110/min, blood pressure 155/95 mmHg, and visible trembling. Her pupils are dilated. Interestingly, she reports that her symptoms are triggered by emotional stress and crowded places, and she has no cardiac pathology on investigation. A diagnosis of panic disorder is made. Which autonomic mechanism is primarily dysregulated in this patient's condition?

Explanation

## Clinical Presentation of Panic Disorder This patient presents with the classic features of panic disorder: - **Acute episodes** of palpitations, chest tightness, and dyspnea - **Psychological trigger** (stress, crowded places) - **Sympathomimetic signs**: tachycardia (110/min), hypertension (155/95), tremor, mydriasis - **Negative cardiac workup** (rules out organic cardiac disease) - **Chronic, recurrent nature** (6-month history) ## Autonomic Dysregulation in Panic Disorder **Key Point:** Panic disorder involves a **dysregulated amygdala-locus coeruleus-sympathetic axis** with excessive noradrenergic tone and impaired parasympathetic buffering. ### The Central Mechanism ```mermaid flowchart TD A[Psychological Stressor<br/>or Threat Perception]:::outcome --> B[Amygdala Hyperactivity]:::outcome B --> C[Locus Coeruleus<br/>Noradrenergic Overfire]:::urgent C --> D[Excessive Central<br/>Sympathetic Outflow]:::action D --> E[Peripheral Sympathetic<br/>Activation]:::action E --> F[Tachycardia, HTN,<br/>Tremor, Mydriasis]:::outcome G[Impaired Parasympathetic<br/>Tone & Vagal Brake]:::urgent --> H[Loss of Autonomic<br/>Counterbalance]:::urgent H --> F I[Defective Negative<br/>Feedback Loop]:::urgent --> J[Failure to Suppress<br/>Locus Coeruleus]:::urgent J --> C ``` **High-Yield:** The **locus coeruleus (LC)** in the brainstem is the primary source of norepinephrine in the CNS. In panic disorder: 1. **Hyperactive LC** → excessive noradrenergic firing 2. **Amygdala hypersensitivity** → interprets benign stimuli as threats 3. **Impaired GABA-ergic inhibition** → reduced tonic suppression of LC 4. **Weak parasympathetic tone** → reduced vagal "brake" on sympathetic activity 5. **Defective negative feedback** → failure of cortisol and other inhibitory signals to suppress LC ### Neurobiological Basis | Component | Dysfunction in Panic Disorder | | --- | --- | | **Locus Coeruleus** | Hyperactive; excessive norepinephrine release | | **Amygdala** | Hypersensitive threat detection | | **Prefrontal Cortex** | Reduced top-down inhibition of amygdala | | **Vagus Nerve (CN X)** | Impaired parasympathetic tone; weak vagal brake | | **GABA-ergic System** | Reduced inhibitory tone on LC | | **HPA Axis Feedback** | Blunted negative feedback; sustained cortisol elevation | **Clinical Pearl:** SSRIs (selective serotonin reuptake inhibitors) are first-line treatment because serotonin **inhibits the locus coeruleus** and enhances prefrontal inhibition of the amygdala—directly counteracting the dysregulation. ### Why Symptoms Occur 1. **Tachycardia & HTN**: Sympathetic β- and α-adrenergic activation 2. **Tremor**: Skeletal muscle β₂-adrenergic stimulation 3. **Mydriasis**: Sympathetic α-adrenergic activation of dilator pupillae 4. **Chest tightness**: Hyperventilation (respiratory alkalosis) + anxiety 5. **Sense of doom**: Amygdala-mediated fear + interoceptive awareness of bodily symptoms **Mnemonic:** **LOCUS = Loss Of Central Utility in Sympathetic Excitation** - **L**ocus coeruleus hyperactivity - **O**veractivity of noradrenergic system - **C**entral sympathetic dysregulation - **U**nbalanced by weak parasympathetic tone - **S**tress-triggered amygdala hyperactivity - **E**xcessive negative feedback failure [cite:Ganong's Review of Medical Physiology 26e Ch 15; Goodman & Gilman's The Pharmacological Basis of Therapeutics 13e Ch 19]